Tetrapyrroles and derivatives
Sigma Organic Chemistry Copper(II) phthalocyanine | 500MG | 147-14-8 | MFCD00010719 | >99.95% trace metals basis
Copper(II) phthalocyanine, 500MG
About This Item:
Storage: room temp
EINECS Number: 205-685-1
eMolecules Zinc phthalocyanine | 14320-04-8 | MFCD00041955 | 25g
Combi-Blocks | Zinc phthalocyanine | 25g | 296392447 | QC-0016 | 95.000 | 14320-04-8 | MFCD00041955 | 577.920 | C32H16N8Zn
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules 3-Hydroxy-4-methyl-2(3H)-thiazolethione | 49762-08-5 | MFCD00077793 | 5g
Combi-Blocks, Inc. | 3-Hydroxy-4-methyl-2(3H)-thiazolethione | 5g | 603151825 | QA-9143 | 95.000 | 49762-08-5 | MFCD00077793 | 147.210 | C4H5NOS2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules 2(3H)-Benzothiazolethione, 5-bromo- | 71216-20-1 | MFCD01569939 | 1g
Combi-Blocks, Inc. | 2(3H)-Benzothiazolethione, 5-bromo- | 1g | 603140428 | QV-3665 | 95.000 | 71216-20-1 | MFCD01569939 | 246.140 | C7H4BrNS2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules 5-Dodecyldihydro-2(3H)-Furanone | 730-46-1 | | 500mg
Toronto Research Chemicals | 5-Dodecyldihydro-2(3H)-Furanone | 500mg | 601595135 | D525920 | | 730-46-1 | | 254.414 | C16H30O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Sigma Aldrich Fine Chemicals Biosciences Methylcobalamin United Sta50MG
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.for further information and support please go to the website of the issuing Pharmacopoeia.
Abcam SB 505124, ALK5 inhibitor, 25MG
MW 335.4 Da, Purity >98%. Potent, reversible, competitive ALK5 inhibitor (IC₅₀ values are 47 and 129 nM for ALK5 and ALK4 respectively). Inhibits ALK7 but not ALK1, 2, 3, or 6. Shows antifibrotic effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 505124, ALK5 inhibitor, 10MG
MW 335.4 Da, Purity >98%. Potent, reversible, competitive ALK5 inhibitor (IC₅₀ values are 47 and 129 nM for ALK5 and ALK4 respectively). Inhibits ALK7 but not ALK1, 2, 3, or 6. Shows antifibrotic effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam S14161, Apoptotic agent.
S14161, Apoptotic agent.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Phomo x anthone A, apoptotic agent, 1MG
MW 750.7 Da, Purity >97%. Cancer cell selective apoptotic agent. Antibiotic agent. Induces apoptosis in cancer cells lines with 100 fold greater potency than noncancerous lines. Shows immunostimulant effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 505124, ALK5 inhibitor, 1MG
MW 335.4 Da, Purity >98%. Potent, reversible, competitive ALK5 inhibitor (IC₅₀ values are 47 and 129 nM for ALK5 and ALK4 respectively). Inhibits ALK7 but not ALK1, 2, 3, or 6. Shows antifibrotic effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 505124, ALK5 inhibitor, 5MG
MW 335.4 Da, Purity >98%. Potent, reversible, competitive ALK5 inhibitor (IC₅₀ values are 47 and 129 nM for ALK5 and ALK4 respectively). Inhibits ALK7 but not ALK1, 2, 3, or 6. Shows antifibrotic effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam L-threo-PDMP, 10MG
MW 427.03 g/mol, Purity >98%. Enantiomer of D-threo-PDMP (Asc 4052). Activates glycosyltransferases for ganglioside biosynthesis. Antineurodegenerative properties. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam D,L-erythro-PDMP, glucosylceramide synthase inhibitor isomer.
D,L-erythro-PDMP, glucosylceramide synthase inhibitor isomer.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Radicicol, Heat shock protein (HSP) 90 inhibitor, 1MG
MW 364.8 Da, Purity >99%. Heat shock protein 90 inhibitor and antifungal antibiotic. Binds to the N-terminal ATP/ADP-binding domain suppressing cell transformation induced by src, ras and mos. Induces cell cycle arrest at G₁-S phase. Shows antiangiogenic effects in vivo.
The product is subject to the following: Abcam Restricted Use Statement